news
Having resolved the structure of psychedelic drugs bound to the…
18 September 2020 | By Hannah Balfour (Drug Target Review)
Having resolved the structure of psychedelic drugs bound to the 5-HT2A serotonin receptor researchers are now developing new therapeutic drugs.